restor3d
Private Company
Total funding raised: $32.8M
Overview
restor3d is a private medical device company at the forefront of personalized orthopedic care, utilizing advanced 3D printing and AI to manufacture patient-specific implants for major joint reconstructions. The company operates a vertically integrated model, controlling design and manufacturing in-house to deliver implants with industry-leading speed, primarily targeting the foot & ankle, knee, and hip markets. By moving beyond traditional 'off-the-shelf' implants, restor3d seeks to address complex anatomical cases and improve surgical precision, positioning itself in the growing market for personalized musculoskeletal solutions. Its technology is underpinned by ongoing research collaborations, such as with Duke University, focusing on osseointegrative biomaterials.
Technology Platform
Proprietary platform integrating advanced 3D printing of osseointegrative biomaterials, AI-based design automation for patient-specific implants, and a vertically integrated digital workflow from imaging to final device.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
restor3d competes in the personalized orthopedic implant space against large medtech players like Stryker (with its Tritanium and 3D-printed offerings) and Zimmer Biomet (Persona), as well as specialized firms like Conformis and Additive Orthopaedics. Competition is based on technology, clinical data, surgeon relationships, and the efficiency of the digital workflow from scan to surgery.